Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Ramelteon in Mild to Moderate Obstructive Sleep Apnea
NCT00672061Phase 2Completed
- Sponsor
- Takeda
- Start
- Jul 2003
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Insomnia comparing Ramelteon 16 mg with Placebo (2 arms). Primary endpoints: Apnea Hypopnea Index, Central Apnea Index and 3 more. Started Jul 2003; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00672061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672061.